Anti-HGF重组抗体|科研级 Rilotumumab ( 利妥木单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-HGF重组抗体|科研级 Rilotumumab ( 利妥木单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-HGF重组抗体|科研级 Rilotumumab ( 利妥木单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1200

Alias

科研级 Rilotumumab ( 利妥木单抗 ), Anti-HGF Recombinant Antibody, Research Grade Rilotumumab

Molecular Name

Rilotumumab

Size

1mg, 5mg

CAS Number

872514-65-3

Isotype

IgG2 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

HGF[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Rilotumumab (previously AMG102) is a human monoclonal antibody designed for the treatment of solid tumors. Rilotumumab was in development by Amgen, Inc. until in November 2014, when Amgen announced it had halted all clinical trials of the compound in advanced gastric cancer (including two Phase III studies) after one of the trials found an increase in the number of deaths in those who were taking rilotumumab and chemotherapy when compared to those who were only administered chemotherapy.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ